Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-27T14:33:06.448Z Has data issue: false hasContentIssue false

Delayed salicylate toxicity following enteric-coated acetylsalicylic acid overdose: a case report and review of the literature

Published online by Cambridge University Press:  21 May 2015

Robert Drummond*
Affiliation:
Department of Emergency Medicine, St. Mary’s Hospital, Montreal, Que.
Nadine Kadri
Affiliation:
Medical Biochemistry, McGill University, Montreal
Julie St-Cyr
Affiliation:
Department of Medical Biochemistry, St. Mary’s Hospital, Montreal
*
St. Mary’s Hospital, 3830 Lacombe Ave., Montreal QC H3T 1M5

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Salicylates are widely available and potentially lethal. Clinical and laboratory findings associated with enteric-coated acetylsalicylic acid (ECASA) ingestion may be delayed more than 24 hours. When dealing with patients who have a history of significant ingestion, emergency physicians should consider initiating therapy regardless of initial salicylate levels. Prolonged observation may be necessary in cases of suspected ECASA overdose.

Type
Case Report • Observations
Copyright
Copyright © Canadian Association of Emergency Physicians 2001

References

1.Done, AK.Salicylate intoxication: significance of measurements of salicylate in blood in cases of acute ingestion. Pediatrics 1960;26:8007.CrossRefGoogle ScholarPubMed
2.Todd, PJ, Sills, JA, Harris, F.Problems with overdoses of sustained release aspirin. Lancet 1981;1:777.CrossRefGoogle ScholarPubMed
3.Kwong, TC, Laczin, J, Baum, J.Self-poisoning with enteric-coated aspirin. Am L Clin Path 1983;80:88890.CrossRefGoogle ScholarPubMed
4.Wortzman, DJ, Grunfeld, A.Delayed absorption following enteric-coated aspiring overdose. Ann Emerg Med 1987;16:4346.CrossRefGoogle Scholar
5.Pierce, RP, Gazewood, J, Blake, RL.Salicylate poisoning from enteric-coated aspirin. Postgrad Med 1991;89:614.CrossRefGoogle ScholarPubMed
6.Gaudreault, P, Temple, AR, Lovejoy, FH.The relative severity of acute versus chronic salicylate poisoning in children: a clinical comparison. Pediatrics 1982;70:5669.CrossRefGoogle ScholarPubMed
7.Needs, CJ, Brooks, PM.Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 1985;10:16477.CrossRefGoogle ScholarPubMed
8.Levy, G.Clinical pharmacokinetics of salicylates: a reassessment. Br J Clin Pharmacol 1980;10:285S290S.CrossRefGoogle ScholarPubMed
9.Dugandzic, RM, Tierney, MG, Dickinson, GE, Dolan, MC, McKnight, DR.Evaluation of the validity of the Done nomogram in the management of acute salicylate intoxication. Ann Emerg Med 1989;18:118690.CrossRefGoogle ScholarPubMed
10.Poisoning with enteric-coated aspirin [editorial]. Lancet 1981; 2:130.Google Scholar
11.Baum, J.Enteric-coated aspirin and the problem of gastric retention. J Rheumatol 1984;11:250.Google ScholarPubMed
12.Bogacz, K, Caldron, P.Enteric-coated aspirin bezoar: elevation of serum salicylate by barium study. Am J Med 1987;83:7836.CrossRefGoogle ScholarPubMed
13.Taylor, JR, Streetman, DS, Castle, SS.Medication bezoars: a literature review and report of a case. Ann Pharmacother 1998; 32:9406.CrossRefGoogle ScholarPubMed